ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Refresh
27 May 2020 03:25

Celltrion H Block Deal: Terms, Overhang, Arb Yield, & Post-Deal Trade Angle

Terms & overhangHere is another deal by OEP on Celltrion Healthcare. 4M shares are on the table (2.64% of the SO). The seller set the discount...

Logo
308 Views
Share
26 May 2020 17:37

A Block Deal Placement (348 Billion Won) Of Celltrion Healthcare by One Equity Partners

After the market close today, it was announced that One Equity Partners private equity firm will sell 348 billion won worth of Celltrion Healthcare...

Logo
331 Views
Share
26 May 2020 16:56

Celltrion Healthcare Placement: Past Performance Bodes Well for Sell-Down Before Lockup Expiry

One Equity Partners is looking to sell 4 m shares in Celltrion Healthcare (091990 KS). Post-placement, One Equity Partners will still have about a...

Logo
280 Views
Share
13 Apr 2020 09:17

Celltrion Healthcare Macro Bull Energy to Test 2018 Highs

Celltrion Healthcare (091990 KS) shows clear risk support to work with for a stop, setting the stage to buy weakness with the summer 2018 highs...

Share
08 Apr 2020 07:10

Big Short Covering on Celltrion Inc & Celltrion Healthcare

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 3 April 2020, the...

Logo
378 Views
Share
x